We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| iRhythm Technologies Inc | NASDAQ:IRTC | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -8.20 | -7.40% | 102.68 | 100.00 | 110.22 | 113.00 | 102.55 | 108.91 | 887,487 | 01:00:00 |
From May 2022 to May 2024
By Chris Wack
iRhythm Technologies Inc. said Friday it received FDA 510(k) clearance for its Zio ECG Utilization Software System for the Zio Watch.
The ZEUS system is produced in partnership with Verily, an Alphabet precision health company.
The ZEUS System is the AI algorithm and solution component of the Zio Watch, a sensor-based wearable for noninvasive, clinical grade, long-term continuous monitoring for atrial fibrillation.
Verily also received FDA 510(k) clearance for the Zio Watch.
iRhythm plans to introduce the ZEUS System for a limited market evaluation in 2023.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
July 22, 2022 08:59 ET (12:59 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year iRhythm Technologies Chart |
1 Month iRhythm Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
